|
Mills Biopharmaceuticals Addition
LOCATION
Oklahoma City, Okla.
OWNER
Mills Biopharmaceuticals, Inc.
ARCHITECT
Glover Smith Bode
SERVICES PROVIDED
General Contracting
PROJECT DATA
19,300 square feet
- Founded more than ten years ago, MBI has been instrumental
in developing leading-edge technologies for the
medical community.
- The new steel frame manufacturing facility
at Mills Biopharmaceuticals, Inc. (MBI) is the
production home of the ProstaSeed TM I-125 Brachytherapy
Sources, a permanent interstitial treatment for tumors.
- The
one-story, brick and metal exterior structure will
be licensed by the US Nuclear Regulatory Commission
to manufacture and store radioactive medical products.
|
